aluates Reports

$ 0.0

Automative

Global Precision Cancer Therapeutics Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-26M13238

Global Precision Cancer Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Precision Cancer Therapeutics Market Research Report 2025

Code: QYRE-Auto-26M13238

Report

April 2025

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Precision Cancer Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Precision Cancer Therapeutics Market

The global market for Precision Cancer Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapeutics.

The Precision Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Precision Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Precision Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Precision Cancer Therapeutics Market
CAGR	5%
Segment by Type	Monoclonal Antibodies Kinase Inhibitors Angiogenesis Inhibitors Proteasome Inhibitors CAR-T Therapies Other Precision Therapies
Segment by Application	Breast Cancer Lung Cancer Prostate Cancer Colon and Rectal Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Astellas Pharma U.S., Inc, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Clovis Oncology, Inc., Dendreon Pharmaceuticals LLC, Eli Lilly & Company, EMD Serono, Inc. (Merck KgaA), Eisai Co., Ltd., Exelixis, Inc., Gilead Sciences, Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Puma Biotechnology, Inc., Roche (F. Hoffman-La Roche, Ltd.), Sanofi/Genzyme, Seagen Inc., Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Precision Cancer Therapeutics Market report?

Ans: The main players in the Precision Cancer Therapeutics Market are AbbVie, Astellas Pharma U.S., Inc, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Clovis Oncology, Inc., Dendreon Pharmaceuticals LLC, Eli Lilly & Company, EMD Serono, Inc. (Merck KgaA), Eisai Co., Ltd., Exelixis, Inc., Gilead Sciences, Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Puma Biotechnology, Inc., Roche (F. Hoffman-La Roche, Ltd.), Sanofi/Genzyme, Seagen Inc., Takeda

What are the Application segmentation covered in the Precision Cancer Therapeutics Market report?

Ans: The Applications covered in the Precision Cancer Therapeutics Market report are Breast Cancer, Lung Cancer, Prostate Cancer, Colon and Rectal Cancer, Others

What are the Type segmentation covered in the Precision Cancer Therapeutics Market report?

Ans: The Types covered in the Precision Cancer Therapeutics Market report are Monoclonal Antibodies, Kinase Inhibitors, Angiogenesis Inhibitors, Proteasome Inhibitors, CAR-T Therapies, Other Precision Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Precision Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibodies

1.2.3 Kinase Inhibitors

1.2.4 Angiogenesis Inhibitors

1.2.5 Proteasome Inhibitors

1.2.6 CAR-T Therapies

1.2.7 Other Precision Therapies

1.3 Market by Application

1.3.1 Global Precision Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Prostate Cancer

1.3.5 Colon and Rectal Cancer

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Precision Cancer Therapeutics Market Perspective (2020-2031)

2.2 Global Precision Cancer Therapeutics Growth Trends by Region

2.2.1 Global Precision Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Precision Cancer Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Precision Cancer Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Precision Cancer Therapeutics Market Dynamics

2.3.1 Precision Cancer Therapeutics Industry Trends

2.3.2 Precision Cancer Therapeutics Market Drivers

2.3.3 Precision Cancer Therapeutics Market Challenges

2.3.4 Precision Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Precision Cancer Therapeutics Players by Revenue

3.1.1 Global Top Precision Cancer Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Precision Cancer Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Precision Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Precision Cancer Therapeutics Revenue

3.4 Global Precision Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Precision Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapeutics Revenue in 2024

3.5 Global Key Players of Precision Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Precision Cancer Therapeutics, Product and Application

3.7 Global Key Players of Precision Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Therapeutics Breakdown Data by Type

4.1 Global Precision Cancer Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Precision Cancer Therapeutics Forecasted Market Size by Type (2026-2031)

5 Precision Cancer Therapeutics Breakdown Data by Application

5.1 Global Precision Cancer Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Precision Cancer Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Precision Cancer Therapeutics Market Size (2020-2031)

6.2 North America Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Precision Cancer Therapeutics Market Size by Country (2020-2025)

6.4 North America Precision Cancer Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Precision Cancer Therapeutics Market Size (2020-2031)

7.2 Europe Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Precision Cancer Therapeutics Market Size by Country (2020-2025)

7.4 Europe Precision Cancer Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Precision Cancer Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Precision Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Precision Cancer Therapeutics Market Size (2020-2031)

9.2 Latin America Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Precision Cancer Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Precision Cancer Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Precision Cancer Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Precision Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Precision Cancer Therapeutics Introduction

11.1.4 AbbVie Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Astellas Pharma U.S., Inc

11.2.1 Astellas Pharma U.S., Inc Company Details

11.2.2 Astellas Pharma U.S., Inc Business Overview

11.2.3 Astellas Pharma U.S., Inc Precision Cancer Therapeutics Introduction

11.2.4 Astellas Pharma U.S., Inc Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.2.5 Astellas Pharma U.S., Inc Recent Development

11.3 AstraZeneca PLC

11.3.1 AstraZeneca PLC Company Details

11.3.2 AstraZeneca PLC Business Overview

11.3.3 AstraZeneca PLC Precision Cancer Therapeutics Introduction

11.3.4 AstraZeneca PLC Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.3.5 AstraZeneca PLC Recent Development

11.4 Bayer AG

11.4.1 Bayer AG Company Details

11.4.2 Bayer AG Business Overview

11.4.3 Bayer AG Precision Cancer Therapeutics Introduction

11.4.4 Bayer AG Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.4.5 Bayer AG Recent Development

11.5 Bristol-Myers Squibb Company

11.5.1 Bristol-Myers Squibb Company Company Details

11.5.2 Bristol-Myers Squibb Company Business Overview

11.5.3 Bristol-Myers Squibb Company Precision Cancer Therapeutics Introduction

11.5.4 Bristol-Myers Squibb Company Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.5.5 Bristol-Myers Squibb Company Recent Development

11.6 Clovis Oncology, Inc.

11.6.1 Clovis Oncology, Inc. Company Details

11.6.2 Clovis Oncology, Inc. Business Overview

11.6.3 Clovis Oncology, Inc. Precision Cancer Therapeutics Introduction

11.6.4 Clovis Oncology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.6.5 Clovis Oncology, Inc. Recent Development

11.7 Dendreon Pharmaceuticals LLC

11.7.1 Dendreon Pharmaceuticals LLC Company Details

11.7.2 Dendreon Pharmaceuticals LLC Business Overview

11.7.3 Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Introduction

11.7.4 Dendreon Pharmaceuticals LLC Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.7.5 Dendreon Pharmaceuticals LLC Recent Development

11.8 Eli Lilly & Company

11.8.1 Eli Lilly & Company Company Details

11.8.2 Eli Lilly & Company Business Overview

11.8.3 Eli Lilly & Company Precision Cancer Therapeutics Introduction

11.8.4 Eli Lilly & Company Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.8.5 Eli Lilly & Company Recent Development

11.9 EMD Serono, Inc. (Merck KgaA)

11.9.1 EMD Serono, Inc. (Merck KgaA) Company Details

11.9.2 EMD Serono, Inc. (Merck KgaA) Business Overview

11.9.3 EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Introduction

11.9.4 EMD Serono, Inc. (Merck KgaA) Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.9.5 EMD Serono, Inc. (Merck KgaA) Recent Development

11.10 Eisai Co., Ltd.

11.10.1 Eisai Co., Ltd. Company Details

11.10.2 Eisai Co., Ltd. Business Overview

11.10.3 Eisai Co., Ltd. Precision Cancer Therapeutics Introduction

11.10.4 Eisai Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.10.5 Eisai Co., Ltd. Recent Development

11.11 Exelixis, Inc.

11.11.1 Exelixis, Inc. Company Details

11.11.2 Exelixis, Inc. Business Overview

11.11.3 Exelixis, Inc. Precision Cancer Therapeutics Introduction

11.11.4 Exelixis, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.11.5 Exelixis, Inc. Recent Development

11.12 Gilead Sciences, Inc.

11.12.1 Gilead Sciences, Inc. Company Details

11.12.2 Gilead Sciences, Inc. Business Overview

11.12.3 Gilead Sciences, Inc. Precision Cancer Therapeutics Introduction

11.12.4 Gilead Sciences, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.12.5 Gilead Sciences, Inc. Recent Development

11.13 GlaxoSmithKline

11.13.1 GlaxoSmithKline Company Details

11.13.2 GlaxoSmithKline Business Overview

11.13.3 GlaxoSmithKline Precision Cancer Therapeutics Introduction

11.13.4 GlaxoSmithKline Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.13.5 GlaxoSmithKline Recent Development

11.14 Johnson & Johnson

11.14.1 Johnson & Johnson Company Details

11.14.2 Johnson & Johnson Business Overview

11.14.3 Johnson & Johnson Precision Cancer Therapeutics Introduction

11.14.4 Johnson & Johnson Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.14.5 Johnson & Johnson Recent Development

11.15 Merck & Co., Inc.

11.15.1 Merck & Co., Inc. Company Details

11.15.2 Merck & Co., Inc. Business Overview

11.15.3 Merck & Co., Inc. Precision Cancer Therapeutics Introduction

11.15.4 Merck & Co., Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.15.5 Merck & Co., Inc. Recent Development

11.16 Novartis AG

11.16.1 Novartis AG Company Details

11.16.2 Novartis AG Business Overview

11.16.3 Novartis AG Precision Cancer Therapeutics Introduction

11.16.4 Novartis AG Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.16.5 Novartis AG Recent Development

11.17 Otsuka Holdings Co., Ltd.

11.17.1 Otsuka Holdings Co., Ltd. Company Details

11.17.2 Otsuka Holdings Co., Ltd. Business Overview

11.17.3 Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Introduction

11.17.4 Otsuka Holdings Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.17.5 Otsuka Holdings Co., Ltd. Recent Development

11.18 Pfizer, Inc.

11.18.1 Pfizer, Inc. Company Details

11.18.2 Pfizer, Inc. Business Overview

11.18.3 Pfizer, Inc. Precision Cancer Therapeutics Introduction

11.18.4 Pfizer, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.18.5 Pfizer, Inc. Recent Development

11.19 Puma Biotechnology, Inc.

11.19.1 Puma Biotechnology, Inc. Company Details

11.19.2 Puma Biotechnology, Inc. Business Overview

11.19.3 Puma Biotechnology, Inc. Precision Cancer Therapeutics Introduction

11.19.4 Puma Biotechnology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.19.5 Puma Biotechnology, Inc. Recent Development

11.20 Roche (F. Hoffman-La Roche, Ltd.)

11.20.1 Roche (F. Hoffman-La Roche, Ltd.) Company Details

11.20.2 Roche (F. Hoffman-La Roche, Ltd.) Business Overview

11.20.3 Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Introduction

11.20.4 Roche (F. Hoffman-La Roche, Ltd.) Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.20.5 Roche (F. Hoffman-La Roche, Ltd.) Recent Development

11.21 Sanofi/Genzyme

11.21.1 Sanofi/Genzyme Company Details

11.21.2 Sanofi/Genzyme Business Overview

11.21.3 Sanofi/Genzyme Precision Cancer Therapeutics Introduction

11.21.4 Sanofi/Genzyme Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.21.5 Sanofi/Genzyme Recent Development

11.22 Seagen Inc.

11.22.1 Seagen Inc. Company Details

11.22.2 Seagen Inc. Business Overview

11.22.3 Seagen Inc. Precision Cancer Therapeutics Introduction

11.22.4 Seagen Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.22.5 Seagen Inc. Recent Development

11.23 Takeda

11.23.1 Takeda Company Details

11.23.2 Takeda Business Overview

11.23.3 Takeda Precision Cancer Therapeutics Introduction

11.23.4 Takeda Revenue in Precision Cancer Therapeutics Business (2020-2025)

11.23.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Precision Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Kinase Inhibitors

Table 4. Key Players of Angiogenesis Inhibitors

Table 5. Key Players of Proteasome Inhibitors

Table 6. Key Players of CAR-T Therapies

Table 7. Key Players of Other Precision Therapies

Table 8. Global Precision Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Precision Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Precision Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Precision Cancer Therapeutics Market Share by Region (2020-2025)

Table 12. Global Precision Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Precision Cancer Therapeutics Market Share by Region (2026-2031)

Table 14. Precision Cancer Therapeutics Market Trends

Table 15. Precision Cancer Therapeutics Market Drivers

Table 16. Precision Cancer Therapeutics Market Challenges

Table 17. Precision Cancer Therapeutics Market Restraints

Table 18. Global Precision Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Precision Cancer Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top Precision Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapeutics as of 2024)

Table 21. Ranking of Global Top Precision Cancer Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Precision Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Precision Cancer Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Precision Cancer Therapeutics, Product and Application

Table 25. Global Key Players of Precision Cancer Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Precision Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Precision Cancer Therapeutics Revenue Market Share by Type (2020-2025)

Table 29. Global Precision Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Precision Cancer Therapeutics Revenue Market Share by Type (2026-2031)

Table 31. Global Precision Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Precision Cancer Therapeutics Revenue Market Share by Application (2020-2025)

Table 33. Global Precision Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Precision Cancer Therapeutics Revenue Market Share by Application (2026-2031)

Table 35. North America Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Precision Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Precision Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Precision Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Precision Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 50. AbbVie Company Details

Table 51. AbbVie Business Overview

Table 52. AbbVie Precision Cancer Therapeutics Product

Table 53. AbbVie Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 54. AbbVie Recent Development

Table 55. Astellas Pharma U.S., Inc Company Details

Table 56. Astellas Pharma U.S., Inc Business Overview

Table 57. Astellas Pharma U.S., Inc Precision Cancer Therapeutics Product

Table 58. Astellas Pharma U.S., Inc Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 59. Astellas Pharma U.S., Inc Recent Development

Table 60. AstraZeneca PLC Company Details

Table 61. AstraZeneca PLC Business Overview

Table 62. AstraZeneca PLC Precision Cancer Therapeutics Product

Table 63. AstraZeneca PLC Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 64. AstraZeneca PLC Recent Development

Table 65. Bayer AG Company Details

Table 66. Bayer AG Business Overview

Table 67. Bayer AG Precision Cancer Therapeutics Product

Table 68. Bayer AG Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 69. Bayer AG Recent Development

Table 70. Bristol-Myers Squibb Company Company Details

Table 71. Bristol-Myers Squibb Company Business Overview

Table 72. Bristol-Myers Squibb Company Precision Cancer Therapeutics Product

Table 73. Bristol-Myers Squibb Company Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 74. Bristol-Myers Squibb Company Recent Development

Table 75. Clovis Oncology, Inc. Company Details

Table 76. Clovis Oncology, Inc. Business Overview

Table 77. Clovis Oncology, Inc. Precision Cancer Therapeutics Product

Table 78. Clovis Oncology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 79. Clovis Oncology, Inc. Recent Development

Table 80. Dendreon Pharmaceuticals LLC Company Details

Table 81. Dendreon Pharmaceuticals LLC Business Overview

Table 82. Dendreon Pharmaceuticals LLC Precision Cancer Therapeutics Product

Table 83. Dendreon Pharmaceuticals LLC Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 84. Dendreon Pharmaceuticals LLC Recent Development

Table 85. Eli Lilly & Company Company Details

Table 86. Eli Lilly & Company Business Overview

Table 87. Eli Lilly & Company Precision Cancer Therapeutics Product

Table 88. Eli Lilly & Company Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 89. Eli Lilly & Company Recent Development

Table 90. EMD Serono, Inc. (Merck KgaA) Company Details

Table 91. EMD Serono, Inc. (Merck KgaA) Business Overview

Table 92. EMD Serono, Inc. (Merck KgaA) Precision Cancer Therapeutics Product

Table 93. EMD Serono, Inc. (Merck KgaA) Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 94. EMD Serono, Inc. (Merck KgaA) Recent Development

Table 95. Eisai Co., Ltd. Company Details

Table 96. Eisai Co., Ltd. Business Overview

Table 97. Eisai Co., Ltd. Precision Cancer Therapeutics Product

Table 98. Eisai Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 99. Eisai Co., Ltd. Recent Development

Table 100. Exelixis, Inc. Company Details

Table 101. Exelixis, Inc. Business Overview

Table 102. Exelixis, Inc. Precision Cancer Therapeutics Product

Table 103. Exelixis, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 104. Exelixis, Inc. Recent Development

Table 105. Gilead Sciences, Inc. Company Details

Table 106. Gilead Sciences, Inc. Business Overview

Table 107. Gilead Sciences, Inc. Precision Cancer Therapeutics Product

Table 108. Gilead Sciences, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 109. Gilead Sciences, Inc. Recent Development

Table 110. GlaxoSmithKline Company Details

Table 111. GlaxoSmithKline Business Overview

Table 112. GlaxoSmithKline Precision Cancer Therapeutics Product

Table 113. GlaxoSmithKline Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 114. GlaxoSmithKline Recent Development

Table 115. Johnson & Johnson Company Details

Table 116. Johnson & Johnson Business Overview

Table 117. Johnson & Johnson Precision Cancer Therapeutics Product

Table 118. Johnson & Johnson Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 119. Johnson & Johnson Recent Development

Table 120. Merck & Co., Inc. Company Details

Table 121. Merck & Co., Inc. Business Overview

Table 122. Merck & Co., Inc. Precision Cancer Therapeutics Product

Table 123. Merck & Co., Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 124. Merck & Co., Inc. Recent Development

Table 125. Novartis AG Company Details

Table 126. Novartis AG Business Overview

Table 127. Novartis AG Precision Cancer Therapeutics Product

Table 128. Novartis AG Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 129. Novartis AG Recent Development

Table 130. Otsuka Holdings Co., Ltd. Company Details

Table 131. Otsuka Holdings Co., Ltd. Business Overview

Table 132. Otsuka Holdings Co., Ltd. Precision Cancer Therapeutics Product

Table 133. Otsuka Holdings Co., Ltd. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 134. Otsuka Holdings Co., Ltd. Recent Development

Table 135. Pfizer, Inc. Company Details

Table 136. Pfizer, Inc. Business Overview

Table 137. Pfizer, Inc. Precision Cancer Therapeutics Product

Table 138. Pfizer, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 139. Pfizer, Inc. Recent Development

Table 140. Puma Biotechnology, Inc. Company Details

Table 141. Puma Biotechnology, Inc. Business Overview

Table 142. Puma Biotechnology, Inc. Precision Cancer Therapeutics Product

Table 143. Puma Biotechnology, Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 144. Puma Biotechnology, Inc. Recent Development

Table 145. Roche (F. Hoffman-La Roche, Ltd.) Company Details

Table 146. Roche (F. Hoffman-La Roche, Ltd.) Business Overview

Table 147. Roche (F. Hoffman-La Roche, Ltd.) Precision Cancer Therapeutics Product

Table 148. Roche (F. Hoffman-La Roche, Ltd.) Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 149. Roche (F. Hoffman-La Roche, Ltd.) Recent Development

Table 150. Sanofi/Genzyme Company Details

Table 151. Sanofi/Genzyme Business Overview

Table 152. Sanofi/Genzyme Precision Cancer Therapeutics Product

Table 153. Sanofi/Genzyme Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 154. Sanofi/Genzyme Recent Development

Table 155. Seagen Inc. Company Details

Table 156. Seagen Inc. Business Overview

Table 157. Seagen Inc. Precision Cancer Therapeutics Product

Table 158. Seagen Inc. Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 159. Seagen Inc. Recent Development

Table 160. Takeda Company Details

Table 161. Takeda Business Overview

Table 162. Takeda Precision Cancer Therapeutics Product

Table 163. Takeda Revenue in Precision Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 164. Takeda Recent Development

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

Table 168. Authors List of This Report

List of Figures

Figure 1. Precision Cancer Therapeutics Picture

Figure 2. Global Precision Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Precision Cancer Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibodies Features

Figure 5. Kinase Inhibitors Features

Figure 6. Angiogenesis Inhibitors Features

Figure 7. Proteasome Inhibitors Features

Figure 8. CAR-T Therapies Features

Figure 9. Other Precision Therapies Features

Figure 10. Global Precision Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Precision Cancer Therapeutics Market Share by Application: 2024 VS 2031

Figure 12. Breast Cancer Case Studies

Figure 13. Lung Cancer Case Studies

Figure 14. Prostate Cancer Case Studies

Figure 15. Colon and Rectal Cancer Case Studies

Figure 16. Others Case Studies

Figure 17. Precision Cancer Therapeutics Report Years Considered

Figure 18. Global Precision Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Precision Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Precision Cancer Therapeutics Market Share by Region: 2024 VS 2031

Figure 21. Global Precision Cancer Therapeutics Market Share by Players in 2024

Figure 22. Global Top Precision Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Therapeutics as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Precision Cancer Therapeutics Revenue in 2024

Figure 24. North America Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Precision Cancer Therapeutics Market Share by Country (2020-2031)

Figure 26. United States Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Precision Cancer Therapeutics Market Share by Country (2020-2031)

Figure 30. Germany Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Precision Cancer Therapeutics Market Share by Region (2020-2031)

Figure 38. China Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Precision Cancer Therapeutics Market Share by Country (2020-2031)

Figure 46. Mexico Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Precision Cancer Therapeutics Market Share by Country (2020-2031)

Figure 50. Turkey Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Precision Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. AbbVie Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 54. Astellas Pharma U.S., Inc Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 55. AstraZeneca PLC Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 56. Bayer AG Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 58. Clovis Oncology, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 59. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 60. Eli Lilly & Company Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 61. EMD Serono, Inc. (Merck KgaA) Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 62. Eisai Co., Ltd. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 63. Exelixis, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 64. Gilead Sciences, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 65. GlaxoSmithKline Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 66. Johnson & Johnson Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 67. Merck & Co., Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 68. Novartis AG Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 69. Otsuka Holdings Co., Ltd. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 70. Pfizer, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 71. Puma Biotechnology, Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 72. Roche (F. Hoffman-La Roche, Ltd.) Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 73. Sanofi/Genzyme Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 74. Seagen Inc. Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 75. Takeda Revenue Growth Rate in Precision Cancer Therapeutics Business (2020-2025)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Personalized Medicine for Cancer Market Research Report 2025

Global Precision Diagnostic Market Research Report 2024

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumor Immunotherapy Market

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Generics Market

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for Breast Cancer Market Research Report 2024

Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »

Global Precision Cancer Therapeutics Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-26M13238

Global Precision Cancer Therapeutics Market Research Report 2025

FEATURED COMPANIES

Precision Cancer Therapeutics Market Size

Precision Cancer Therapeutics Market

Scope of Precision Cancer Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Precision Cancer Therapeutics Market report?

What are the Application segmentation covered in the Precision Cancer Therapeutics Market report?

What are the Type segmentation covered in the Precision Cancer Therapeutics Market report?

FEATURED COMPANIES